EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?

EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?

Abstract Lung cancer is the leading cause of cancer‐related death globally and poses a considerable threat to public health. Asia has the highest prevalence of epidermal growth factor receptor (EGFR) mutations in patients with non‐small cell lung cancer (NSCLC). Despite the reasonable response and p...

Full description

Bibliographic Details
Main Authors: Bailong Liu, Hui Liu, Yunfei Ma, Qiuhui Ding, Min Zhang, Xinliang Liu, Min Liu
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Cancer Medicine
Subjects:
EGFR mutation
radiotherapy
TKI
Online Access:https://doi.org/10.1002/cam4.4192

Internet

https://doi.org/10.1002/cam4.4192

Similar Items